Recruiting
A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS
NCT06249867
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Ottawa Hospital Research Institute Ottawa, Ontario, Canada
- Montreal Neurological Institute Montreal, Quebec, Canada